Table 2. EBV antibodies in SLE patients and healthy controls (%).
EBNA-1 | EBV-VCA | EBV-EA/D | |||||||
---|---|---|---|---|---|---|---|---|---|
IgG | IgA | IgM | IgG | IgA | IgM | IgG | IgA | IgM | |
SLE patients (n = 45) | 82 | 0 | 0 | 100 | 18 | 16 | 62 | 58 | 67 |
Healthy controls (n = 40) | 75 | 0 | 2.5 | 82.5 | 5 | 5 | 18 | 13 | 23 |
p-values for comparison | NS | NS | NS | NS | 0.003 | 0.0007 | 0.0001 | ~0 | 0.0001 |
EBV—Epstein-Barr virus, SLE—systemic lupus erythematosus, EBNA-1 –EBV nuclear antigen 1, EBV-VCA—EBV viral capsid antigen, EBV-EA/D—EBV early antigen diffuse, NS—not significant.